Cargando…
Reassessing the Safety of Pill-in-the-Pocket Propafenone
The current guidelines state that propafenone can be used in combination with a beta-blocker or a calcium channel blocker for pharmacologic cardioversion of recent-onset atrial fibrillation in patients without structural heart disease. To prevent the conversion from atrial fibrillation to atrial flu...
Autores principales: | Kim, Andrew G, Yavari, Majid, Sabanci, Rand, Ukponmwan, Esosa, Ali-Ahmed, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614079/ https://www.ncbi.nlm.nih.gov/pubmed/37908936 http://dx.doi.org/10.7759/cureus.46282 |
Ejemplares similares
-
Assessing and Reassessing the Association of Comorbidities and Coinfections in COVID-19 Patients
por: Khan, Aryaan, et al.
Publicado: (2023) -
“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism
por: Li, Linling, et al.
Publicado: (2019) -
Extensively Drug-Resistant Salmonella typhi Infection: From Pill to Scalpel
por: Rahim, Fawad, et al.
Publicado: (2022) -
Massive Intracerebral Hemorrhage Following Injudicious Use of Combined Oral Contraceptive Pills
por: Gaikwad, Vidya, et al.
Publicado: (2023) -
Propafenone and propranolol dual toxicity
por: Farooq, Moonis, et al.
Publicado: (2020)